European journal of rheumatology最新文献

筛选
英文 中文
Orbital Masses in Granulomatosis with Polyangiitis: A Call for Clinical Vigilance. 肉芽肿伴多血管炎的眼眶肿块:呼吁临床警惕。
IF 1.3
European journal of rheumatology Pub Date : 2024-09-05 DOI: 10.5152/eurjrheum.2024.24029
Isabel Fonseca Silva, Cristina Freitas, Tomás Fonseca
{"title":"Orbital Masses in Granulomatosis with Polyangiitis: A Call for Clinical Vigilance.","authors":"Isabel Fonseca Silva, Cristina Freitas, Tomás Fonseca","doi":"10.5152/eurjrheum.2024.24029","DOIUrl":"https://doi.org/10.5152/eurjrheum.2024.24029","url":null,"abstract":"","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 2","pages":"64-65"},"PeriodicalIF":1.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the Gut Microbiome in Patients with Psoriatic Arthritis. 银屑病关节炎患者肠道微生物组研究
IF 1.3
European journal of rheumatology Pub Date : 2024-09-05 DOI: 10.5152/eurjrheum.2024.23080
Gustavo Moreira Amorim, Gláucio Ricardo Werner Castro, Sueli Carneiro
{"title":"Study of the Gut Microbiome in Patients with Psoriatic Arthritis.","authors":"Gustavo Moreira Amorim, Gláucio Ricardo Werner Castro, Sueli Carneiro","doi":"10.5152/eurjrheum.2024.23080","DOIUrl":"https://doi.org/10.5152/eurjrheum.2024.23080","url":null,"abstract":"<p><strong>Background: </strong>Gut dysbiosis may play a role in immune-mediated diseases, such as psoriasis. There is a growing interest in understanding microbiome influence, with speculations around the importance of an altered gut microbiome linked to the progression to psoriatic arthritis in psoriasis. The objective of this study is to study the gut microbiome in patients with severe psoriatic disease with or without psoriatic arthritis.</p><p><strong>Methods: </strong>V3/V4 16S rRNA gene sequencing and bioinformatics analyses were performed with the total DNA extracted from the stool samples of 30 patients with psoriatic disease, 15 of whom had documented psoriatic arthritis.</p><p><strong>Results: </strong>We found differences in gut microbiome composition in psoriatic arthritis patients when looking for relative and especially differential abundances. Bacteroidaceae family (P = .02), Bacteroides genus (P=.02), and Bacteroides uniformis (P=.03) were more abundant in psoriatic arthritis patients on differential abundance, adjusted for each taxonomic level. However, the present study did not show significant differences in alpha or beta diversity.</p><p><strong>Conclusion: </strong>This study shows different patterns of gut microbiome composition in patients with psoriatic arthritis, with significant overexpression of the Bacteroides genus. This reinforces the microbiome as a field of interest in psoriasis. Nevertheless, it should be noted that some previously described findings related to lower diversity and different clustering between groups could not be demonstrated, probably due to the small number of patients. Additionally, it remains difficult to understand the magnitude of the gut microbiome influence. Is dysbiosis a cause or consequence of the disease? However, the microbiome deserves our attention, especially since it brings different opportunities for intervention through diet, prebiotics and probiotics, pretreatment analysis, prognosis, and even microbiome modulation and transplantation.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 2","pages":"46-52"},"PeriodicalIF":1.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and Psychometric Evaluation of the Profile of Fatigue and Discomfort-Sicca Symptoms Inventory (Short Form) for Patients with Primary Sjögren's Syndrome: Validity and Reliability Analysis of the Turkish Version. 原发性斯约格伦综合征患者疲劳与不适--西卡症状量表(简表)的翻译与心理测量学评估:土耳其语版本的有效性和可靠性分析。
IF 1.3
European journal of rheumatology Pub Date : 2024-07-26 DOI: 10.5152/eurjrheum.2024.24009
Fulden Sari, Selin Bayram, Gamze Gülsün Pala, Deran Oskay, Abdurrahman Tufan
{"title":"Translation and Psychometric Evaluation of the Profile of Fatigue and Discomfort-Sicca Symptoms Inventory (Short Form) for Patients with Primary Sjögren's Syndrome: Validity and Reliability Analysis of the Turkish Version.","authors":"Fulden Sari, Selin Bayram, Gamze Gülsün Pala, Deran Oskay, Abdurrahman Tufan","doi":"10.5152/eurjrheum.2024.24009","DOIUrl":"https://doi.org/10.5152/eurjrheum.2024.24009","url":null,"abstract":"<p><strong>Background: </strong>The study aimed to translate the Profile of Fatigue and Discomfort-Sicca Symptoms Inventory Short Form questionnaire into the Turkish language (PROFAD-SSI-SF-T) and to investigate its psychometric properties.</p><p><strong>Methods: </strong>The study was completed by 104 patients with primary Sjögren's syndrome (pSS), and 83 patients filled out the scale a second time after 7 days for the retest measurement. The PROFAD-SSISF-T, Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), European Quality of Life 5 Dimensions (EQ-5D), and Patient Global Assessment (PaGA) were applied to 104 patients with pSS for convergent validity.</p><p><strong>Results: </strong>PROFAD-SSI-SF-T found excellent internal consistency (Cronbach's α=0.935) and high test- retest reliability (ICC: 0.83; 95% CI: 0.75-0.88). The standard error of measurement ranged from 1.01 to 3.52, and the minimum detectable difference ranged from 0.92 to 1.17. There was a range from low to high correlation between the PROFAD-SSI-SF-T with ESSPRI, FACIT-F, and EQ-5D. There were no floor and ceiling effects in the PROFAD-SSI-SF-T scale.</p><p><strong>Conclusion: </strong>The PROFAD-SSI-SF-T is a valid and reliable scale to evaluate fatigue, discomfort, and sicca symptoms in Turkish patients with primary Sjögren's syndrome.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 1","pages":"20-26"},"PeriodicalIF":1.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decreased Aortic Elasticity in Rheumatoid Arthritis: An Early Sign of Atherosclerosis and Predictive Factors. 类风湿性关节炎患者主动脉弹性降低:动脉粥样硬化的早期征兆和预测因素
IF 1.3
European journal of rheumatology Pub Date : 2024-07-26 DOI: 10.5152/eurjrheum.2024.24010
Mehtap Ucer, Betul Cengiz, Sukru Taylan Sahin, Sule Yavuz, Neslihan Yilmaz
{"title":"Decreased Aortic Elasticity in Rheumatoid Arthritis: An Early Sign of Atherosclerosis and Predictive Factors.","authors":"Mehtap Ucer, Betul Cengiz, Sukru Taylan Sahin, Sule Yavuz, Neslihan Yilmaz","doi":"10.5152/eurjrheum.2024.24010","DOIUrl":"https://doi.org/10.5152/eurjrheum.2024.24010","url":null,"abstract":"<p><strong>Background: </strong>Atherosclerosis is increased in patients with rheumatoid arthritis (RA) and early diagnosis of vascular disease leads to better outcome. Our aim was to evaluate whether aortic elasticity decreases in the subclinical stage of atherosclerosis in RA patients without any cardiovascular disease and to determine disease-related risk factors.</p><p><strong>Methods: </strong>One hundred fourteen patients with RA, 50 patients with spondyloarthritis, and 50 healthy control were included in this study. Aortic elasticity was evaluated by echocardiography (ECHO). The relationship between atherosclerosis and vascular risk factors, including age, disease activity, C-reactive protein, and serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) levels was investigated.</p><p><strong>Results: </strong>In ECHO evaluation, aortic stiffness was increased (P=.01), and aortic strain and elasticity were decreased (P < .01, P=.01) in RA patients compared to control groups. Serum tumor necrosis factor-like weak inducer of apoptosis levels were also significantly lower (P < .01) in RA, but no significant correlation was found with aortic strain measurement (P > .05). Aortic elasticity was shown to decrease significantly with age in all groups (P < .05).</p><p><strong>Conclusion: </strong>In this study, we observed deterioration of aortic parameters indicating early atherosclerosis in RA. Aging was found to be the single predictive factor for vascular disease. Although a decrease in sTWEAK level was detected in the RA group, no statistically significant relationship could be demonstrated between sTWEAK level and aortic elasticity parameters. However, the cross-sectional design of the study and possible fluctuations in serum markers depending on disease activity make it difficult to draw a clear conclusion on this subject.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 1","pages":"8-12"},"PeriodicalIF":1.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between Immunoglobulin G4-Related Eye Disease and Other Entities with Non-Immunoglobulin G4 Ocular Involvement. 免疫球蛋白 G4 相关眼病与其他非免疫球蛋白 G4 眼部受累实体的比较。
IF 1.3
European journal of rheumatology Pub Date : 2024-07-26 DOI: 10.5152/eurjrheum.2024.23094
Zunino Luisina Victoria, Schmid María Marcela, Calvo Romina Andrea, Jesica Romina Gallo, Paira Sergio
{"title":"Comparison between Immunoglobulin G4-Related Eye Disease and Other Entities with Non-Immunoglobulin G4 Ocular Involvement.","authors":"Zunino Luisina Victoria, Schmid María Marcela, Calvo Romina Andrea, Jesica Romina Gallo, Paira Sergio","doi":"10.5152/eurjrheum.2024.23094","DOIUrl":"https://doi.org/10.5152/eurjrheum.2024.23094","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Distinguishing immunoglobulin G4 (IgG4)-related disease ocular involvement (IgG4-ROD) from other non-IgG4 pathologies in the orbit and eyeball is often complex. The objective was to compare clinical, analytical, imaging, and anatomopathological features of IgG4-ROD with other inflammatory and/or autoimmune ocular diseases (non-IgG4-ROD).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;An observational, descriptive, and retrospective study included 18 patients diagnosed with IgG4-ROD according to Umehara's 2011 and/or 2020 comprehensive criteria, from 3 centers. Additionally, 12 patients with non-IgG4-ROD between 2014 and 2022 were selected, forming 2 groups. Data collection involved visualizing medical records. Demographic profile, clinical manifestations, analytical, histopathological, and radiological findings were analyzed using SPSS Statistics 19. Categorical variables were presented as frequencies and percentages, and continuous variables as means with standard deviation or median with interquartile range. Proportions were compared using the chi-square test, and means and medians were compared using T-tests and nonparametric tests. A confidence level of α=.05 was selected.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Thirty patients were analyzed: 18 with IgG4-ROD and 12 with non-IgG4-ROD. Among the latter, diagnoses included Histiocytosis (n=4), Amyloidosis (n=3), malignant secondary malignancy (n=2), and other conditions (n=3). Female sex predominated in IgG4-ROD (78% vs. 50%, P=.12). Mean age was 44 years, with no group difference (P=.26). Bilateral involvement was more common in non-IgG4 (92% vs. 72%, P=.21). Predominant symptoms in IgG4-ROD were proptosis, ocular pain, xerophthalmia, palpebral edema, and diplopia, while palpebral edema and ocular motility disturbance were more usual in other pathologies. Proptosis, xerophthalmia, and diplopia were significantly more frequent in IgG4-ROD (P=.042, P=.021, P=.021, respectively). Parotid involvement showed significant association in IgG4-ROD at 33% (P=.031). Statistically significant differences were observed in elevated serum IgG4 levels (67%, P=.002), IgG (P=.037), and IgG2 levels ≥ 5.3 g/L (56%, P=.023) in IgG4-ROD. There was also a significant difference between the association of eosinophilia and the non-IgG4 group (67% vs. 22%, P=.034), as did mean serum IgG value and the IgG4-ROD group (P=.037). Lacrimal gland involvement associated with IgG4-ROD (P=.032). Histopathologically, IgG4- ROD showed significant associations with lymphoplasmacytic infiltrate (100%, P=.004), storiform fibrosis (36%, P=.05), and presence of Eosinophils (64%, P=.003).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Immunoglobulin G4-related ophthalmic disease showed significant associations with xerophthalmia, proptosis, diplopia, and parotid involvement. Elevated serum IgG4, IgG, and IgG2 levels were also linked to this condition. Imaging studies revealed lacrimal gland involvement. Furthermore, lymphoplasmacytic infilt","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 1","pages":"13-19"},"PeriodicalIF":1.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound for the Diagnosis of Giant Cell Arteritis. 超声波诊断巨细胞动脉炎。
IF 1.3
European journal of rheumatology Pub Date : 2024-07-05 DOI: 10.5152/eurjrheum.2024.20104
Paula Valentina Estrada Alarcón, Patricia Moya Alvarado, Elena Leonor Sirvent Alierta
{"title":"Ultrasound for the Diagnosis of Giant Cell Arteritis.","authors":"Paula Valentina Estrada Alarcón, Patricia Moya Alvarado, Elena Leonor Sirvent Alierta","doi":"10.5152/eurjrheum.2024.20104","DOIUrl":"10.5152/eurjrheum.2024.20104","url":null,"abstract":"<p><p>Giant cell arteritis (GCA) is the most frequent large vessel primary vasculitis in the elderly. Correct diagnosis and fast assessment are necessary to prevent complications as well as unnecessary treatments. Giant cell arteritis can present as classical cranial symptoms or as extracranial disease. Although temporal artery biopsy is still the gold standard, ultrasound (US) is gaining ground on evidence with good diagnostic performance as a first approach to support the clinical criteria. The \"halo\" sign is the most characteristic finding and should be a requisite for reporting an US assessment for GCA with a 43%- 77% sensitivity and 89%-100% specificity, when compared to American College of Rheumatology 1990 criteria. Ultrasound is a cost-effective, noninvasive test that offers bed-side results. The need for an experienced sonographer and consensus on the methodology and interpretation of US is fundamental to reduce operator-dependent errors. The diagnostic US algorithm for GCA depends on the clinical scenarios, and in some cases it may be enough to confirm or discard the GCA diagnosis. We review procedure details for cranial and extracranial arteries and technical requirements.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 3","pages":"S283-S289"},"PeriodicalIF":1.3,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound Evaluation of Soft Tissue Masses and Parotid Gland in Clinical Rheumatology. 临床风湿病学中的软组织肿块和腮腺超声评估。
IF 1.3
European journal of rheumatology Pub Date : 2024-07-02 DOI: 10.5152/eurjrheum.2024.20191
Hèctor Corominas, Delia Reina, Vanessa Navarro, Oscar Camacho
{"title":"Ultrasound Evaluation of Soft Tissue Masses and Parotid Gland in Clinical Rheumatology.","authors":"Hèctor Corominas, Delia Reina, Vanessa Navarro, Oscar Camacho","doi":"10.5152/eurjrheum.2024.20191","DOIUrl":"10.5152/eurjrheum.2024.20191","url":null,"abstract":"<p><p>Soft tissue masses are very common and may appear in the context of rheumatic diseases. They usually occur alone but may occasionally be part of the syndromes and can sometimes involve periarticular tissues. Soft tissue masses can be divided into several categories. In this article, we have categorized them into 3 different groups: (1) pseudotumors, (2) benign tumors, and (3) malignant tumors. Parotid enlargement will also be discussed in this study. The majority of Soft tissue masses are pseudotumors or benign tumors, which can be easily characterized with ultrasound, therefore, considered the first screening tool in the study of this type of lesion. If the tumor is deep or poorly accessible, or present with suspected signs of malignancy, the sonographer may suggest expanding the study with magnetic resonance imaging and/or an ultrasound-guided biopsy of the lesion. Ultrasound is also a good technique for the parotid and submandibular glands and is very useful for evaluating and monitoring Sjogren's syndrome.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 3","pages":"S290-S297"},"PeriodicalIF":1.3,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Special Issue on Osteoarthritis: Risk Factors and Treatment Strategies. 骨关节炎特刊:风险因素与治疗策略
IF 1.3
European journal of rheumatology Pub Date : 2024-05-01 DOI: 10.5152/eurjrheum.2024.220124
Devyani Misra
{"title":"Special Issue on Osteoarthritis: Risk Factors and Treatment Strategies.","authors":"Devyani Misra","doi":"10.5152/eurjrheum.2024.220124","DOIUrl":"10.5152/eurjrheum.2024.220124","url":null,"abstract":"<p><p>Cite this article as: Misra D. Special issue on osteoarthritis: Risk factors and treatment strategies. Eur J Rheumatol. 2024;11(suppl 1):S1-S2.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":"11 1","pages":"S1-S2"},"PeriodicalIF":1.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression. 继发于风湿性疾病的淀粉样A蛋白淀粉样变性的2019年冠状病毒病结果和2019年冠状病毒病后蛋白尿进展的迹象。
IF 1.3
European journal of rheumatology Pub Date : 2024-04-04 DOI: 10.5152/eurjrheum.2024.23050
Serdar Can Güven, Abdulsamet Erden, Hamit Küçük, Hakan Apaydın, Bünyamin Polat, Rıza Can Kardaş, Derya Yıldırım, Eren Usul, Berkan Armağan, Orhan Küçükşahin, Ahmet Omma, Abdurrahman Tufan
{"title":"Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression.","authors":"Serdar Can Güven, Abdulsamet Erden, Hamit Küçük, Hakan Apaydın, Bünyamin Polat, Rıza Can Kardaş, Derya Yıldırım, Eren Usul, Berkan Armağan, Orhan Küçükşahin, Ahmet Omma, Abdurrahman Tufan","doi":"10.5152/eurjrheum.2024.23050","DOIUrl":"10.5152/eurjrheum.2024.23050","url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate coronavirus diease 2019 (COVID-19) outcomes in patients with amyloid A protein (AA) amyloidosis secondary to rheumatic diseases and discuss factors associated with disease course.</p><p><strong>Methods: </strong>A retrospective cohort was formed from adult patients with a diagnosis of AA amyloidosis. In patients with a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction (PCR) test, rates of hospitalization, intensive care unit admission and mortality due to COVID-19 were collected from medical records. Data regarding to demographics, comorbidities, laboratory tests, medical treatments, adherence to previous treatments during COVID-19 and treatment administered for COVID-19 were collected from hospital databases and patient reviews.</p><p><strong>Results: </strong>In 96 patients with AA amyloidosis, 16 had COVID-19 with a positive PCR. Ten (62.5%) patients were hospitalized, 2 (12.5%) were admitted to ICU, 1 (6.25%) was died. Hospitalized patients tended to be older. Comorbidities seemed to be more frequent in hospitalized patients. None of the patients had rapid progression to end-stage renal disease post-COVID-19. Seven patients had pre-COVID-19 and post-COVID-19 proteinuria levels. Three had notable increase in proteinuria after COVID-19 in 2 of which amyloidosis treatment was revised accordingly.</p><p><strong>Conclusion: </strong>Despite high rates of hospitalization in AA amyloidosis patients, mortality was observed only in 1 patient. Progression of proteinuria requiring treatment adjustment may be an issue in these patients. Cite this article as: Güven SC, Erden A, Küçük H, et al. Coronavirus disease 2019 outcomes in amyloid A protein amyloidosis secondary to rheumatic conditions and signs of post-coronavirus disease 2019 proteinuria progression. Eur J Rheumatol. Published online April 4, 2024. DOI:10.5152/eurjrheum.2024.23050.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11365016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-Based Review of Nonsurgical Treatments for Knee and Hip Osteoarthritis. 基于证据的膝关节和髋关节骨性关节炎非手术疗法回顾。
IF 1.9
European journal of rheumatology Pub Date : 2024-03-25 DOI: 10.5152/eurjrheum.2024.22096
Devyani Misra, David T Felson
{"title":"Evidence-Based Review of Nonsurgical Treatments for Knee and Hip Osteoarthritis.","authors":"Devyani Misra, David T Felson","doi":"10.5152/eurjrheum.2024.22096","DOIUrl":"10.5152/eurjrheum.2024.22096","url":null,"abstract":"<p><p>Knee and hip osteoarthritis (OA) are highly prevalent joint diseases that lead to chronic pain, disability, and increased mortality. In this review, we provide a summary of nonsurgical treatments available for knee and hip OA that have evidence to support their use. We also provide a summary of the treatments available for knee and hip OA that do not have sufficient evidence to support their use. Treatments covered in this review include pharmacologic and nonpharmacologic modalities. Cite this article as: Misra D, Felson DT. Evidence-based review of nonsurgical treatments for knee and hip osteoarthritis. Eur J Rheumatol. Published online March 25, 2024. doi: 10.5152/ eurjrheum.2024.22096.</p>","PeriodicalId":12066,"journal":{"name":"European journal of rheumatology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信